Uptake of amiodarone by thyroidal and non-thyroidal cell lines.
Amiodarone perturbs thyroid function, causing overt hypothyroidism or hyperthyroidism in 15% of patients. Changes in thyroid function are likely due, at least in part, to amiodarone and/or desethylamiodarone (DEA) concentration into the thyroid gland, but mechanisms whereby the drug uptake occurred are not known. Thyroidal (FRTL-5) or non-thyroidal [Chinese hamster ovary wild-type (CHOwt) or CHO stably transfected with NIS (CHO-NIS)] cells were exposed to 10 microM amiodarone or DEA. Cellular content of both drugs was measured by HPLC and normalized by protein concentration. Cellular concentration of the two drugs was higher in FRTL-5 (mean +/- SD 17.2 +/- 1.2 microg/mg protein of amiodarone and 18.9 +/- 0.7 microg/mg protein of DEA) than in CHO-NIS and CHOwt cells (10.8 +/- 0.8 microg/mg protein and 12.8 +/- 0.2 microg/mg protein, respectively, of amiodarone (p < 0.004); 11.9 +/- 0.1 microg/mg protein and 11 +/- 0.2 microg/mg protein, respectively, of DEA (p < 0.0002). DEA concentration was higher than that of amiodarone in all cell lines (p < 0.002). Differences between FRTL-5 and CHO cell lines were not dependent on TSH: in fact, cellular content of either drug did not change in the presence or absence of TSH in the culture medium. NIS did not intervene in amiodarone or DEA entry into thyroid cells, since amiodarone and DEA content was the same in CHOwt and CHO-NIS cells; in addition, KClO4 inhibited NIS function, but had no effect on drug uptake by the cells. At variance, 80 microM DEA reduced 125I uptake by CHO-NIS cells by 40% at 30 min without affecting cell viability. In conclusion, mechanisms whereby amiodarone is taken up by thyroid cells remain largely unknown, but the two main factors involved in thyroid-specific cellular transport, ie, NIS and TSH, seem to be excluded.
Bogazzi
F
F
Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy. fbogazzi@hotmail.com
Raggi
F
F
Ultimieri
F
F
Russo
D
D
Cosci
C
C
Cecchetti
P
P
Dell'Unto
E
E
Sardella
C
C
Tonacchera
M
M
Vitti
P
P
Benzi
L
L
Bartalena
L
L
Martino
E
E
D000638:Amiodarone / Q000031:analogs & derivatives / Q000493:pharmacokinetics* / Q000494:pharmacology; D000818:Animals; D016466:CHO Cells; D002460:Cell Line; D006224:Cricetinae; D003412:Cricetulus; D007455:Iodine / Q000493:pharmacokinetics; D010472:Perchlorates / Q000494:pharmacology; D017680:Potassium Compounds / Q000494:pharmacology; D027981:Symporters / Q000235:genetics; D013961:Thyroid Gland / Q000187:drug effects / Q000378:metabolism*; D014162:Transfection; D000099209:Sodium-Iodide Symporters
D000638:Amiodarone; D007455:Iodine; D010472:Perchlorates; D017680:Potassium Compounds; D027981:Symporters; D000099209:Sodium-Iodide Symporters; C009006:potassium perchlorate; C036116:desethylamiodarone